PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24567279-1	2014	BACKGROUND: The antiepileptic drug lacosamide has a low potential for drug-drug interactions, but is a substrate and moderate inhibitor of the cytochrome P450 (CYP) enzyme CYP2C19.	Lacosamide	35-45	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	143-158	
23859801-4	2013	Lacosamide has a well-characterized and favorable pharmacokinetic profile, including a fast absorption rate, minimal or no interaction with cytochrome P-450 izoenzymes, and a low potential for drug-drug interactions.	Lacosamide	0-10	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	140-156	
24567279-1	2014	BACKGROUND: The antiepileptic drug lacosamide has a low potential for drug-drug interactions, but is a substrate and moderate inhibitor of the cytochrome P450 (CYP) enzyme CYP2C19.	Lacosamide	35-45	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	160-163